Follow-The-Filings

Security · featured owners

ANIK Anika Therapeutics Inc.

Health Care COM Equity among managers we track

ANIK (Anika Therapeutics Inc.) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

SEC filings

Recent issuer filings from EDGAR · 17 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
DEFA14A Filing Doc
10-K FORM 10-K Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
8-K 2.02,5.02,9.01 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 10 rows shown

Filed Form Detail Links
4 Period Aug 3, 2026 Filing Doc
4 Period Jun 18, 2026 · 5 forms Filing Doc
4 Period Jun 3, 2026 Filing Doc
4 Period May 1, 2026 Filing Doc
4 Period Apr 30, 2026 Filing Doc
4 Period Mar 19, 2026 Filing Doc
4 Period Mar 14, 2026 · 4 forms Filing Doc
4 Period Mar 9, 2026 · 3 forms Filing Doc
4 Period Feb 1, 2026 Filing Doc
4 Period Jun 20, 2025 · 5 forms Filing Doc

Updated 6 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $166.66M $119.91M $112.82M
Gross profit $103.09M $76M $63.81M
Gross margin * 61.9% 63.4% 56.6%
Net income -$82.67M -$56.38M -$10.88M
Net margin * -49.6% -47.0% -9.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $163.31M $113.65M $103.36M
Total non-current assets * $107.32M $89.09M $86.91M
Total assets $270.63M $202.74M $190.27M
Total current liabilities $31.06M $23.31M $21.91M
Total equity $212.26M $153.99M $143.46M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$1.79M $5.4M $11.19M
Cash from investing -$5.43M -$8.33M -$0.401M
Cash from financing -$6.32M -$12.73M -$10.55M
Net change in cash -$13.46M -$15.71M $0.322M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders